LAS1L and triple-negative breast carcinoma: Among them, Dr. Samant ‘s research shows that knockdown of LAS1L leads to a sharp reduction in tumorigenic and metastatic properties in triple-negative breast cancer (20), which is similar to Dr. Vincent’s conclusion.